通过使用溶剂探针进行分子动力学模拟来解开CYP3A4的质结合部位
Yanjun Feng1, Changda Gong1, Jieyu Zhu1
1Shanghai Frontiers Science Center of Optogenetic Techniques for Cell Metabolism, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, 130 Meilong Road, Shanghai 200237, China.
Journal of chemical information and modeling
|April 9, 2024
概括
研究人员在重要的药物代谢酶Cytochrome P450 3A4 (CYP3A4) 上发现了新的药物结合部位. 这一发现有助于解释其复杂的行为,并可能导致更好的药物开发.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 计算生物学 计算生物学
背景情况:
- 细胞染色体P450 3A4 (CYP3A4) 是一种具有复杂动力学的关键人类药物代谢酶.
- 众所周知,多个结合位,可能导致与活性位点的全干扰,会影响CYP3A4的活性.
- 了解这些额外连接体结合点对于破译CYP3A4的非典型特征和连接体-受体相互作用至关重要.
研究的目的:
- 探索CYP3A4中超出正规活性部位的潜在联结部位.
- 为了研究这些位点在酶复杂的动力行为中的作用.
- 为了更好地理解药物相互作用,确定新的结合位置.
主要方法:
- 利用混合溶剂分子动力学 (MixMD) 模拟来识别潜在的联结位点,利用受体灵活性.
- 采用在线计算预测工具来帮助网站识别.
- 进行了集体对接和常规分子动力学 (cMD) 模拟,以进一步验证已识别的地点.
主要成果:
- 混合MD方法在处理网站识别的受体灵活性方面证明是有效的.
- 在CYP3A4中确定了三个适合联体结合的额外部位.
- 其中包括一个先前已确认的结合地点和两个新发现的结合地点.
结论:
- 该研究成功地使用先进的计算方法在CYP3A4中确定了新型的配体结合位.
- 这些发现有助于更深入地了解CYP3A4的复杂动力学和全调节.
- 已识别的地点为未来的药物设计和优化策略提供了潜在的目标.
相关概念视频
Ligand Binding Sites
12.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.8K
Conserved Binding Sites
4.2K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.2K
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
The Equilibrium Binding Constant and Binding Strength
12.9K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
12.9K
Allosteric Proteins-ATCase
5.7K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.7K


